Stay updated on Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.

Latest updates to the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA site-wide NIH notice announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe footer’s site revision number changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the previous study content. This blocks access to the study details on that page.SummaryDifference19%

- Check49 days agoChange DetectedThe page's revision label updated from v3.6.6 to v3.7.0, indicating a software version update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page footer now displays Revision: v3.6.6 instead of v3.6.5, indicating a new build deployment.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a minor site update with no changes to study information or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo in Clear-Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo in Clear-Cell RCC Clinical Trial page.